{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:44:50Z","timestamp":1778895890890,"version":"3.51.4"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["009\/2559"],"award-info":[{"award-number":["009\/2559"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0234186","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T17:34:41Z","timestamp":1591378481000},"page":"e0234186","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial"],"prefix":"10.1371","volume":"15","author":[{"given":"Ngamjit","family":"Kasetsuwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanawat","family":"Chantaralawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usanee","family":"Reinprayoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2111-1271","authenticated-orcid":true,"given":"Lita","family":"Uthaithammarat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"issue":"2","key":"pone.0234186.ref001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"The ocular surface"},{"key":"pone.0234186.ref002","first-page":"3043","article-title":"Efficiency and safety of subconjunctival injection of anti-VEGF agent\u2014bevacizumab\u2014in treating dry eye","volume":"9","author":"X Jiang","year":"2015","journal-title":"Drug design, development and therapy"},{"issue":"1","key":"pone.0234186.ref003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.eye.6701811","article-title":"Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis","volume":"20","author":"AM Abu El-Asrar","year":"2006","journal-title":"Eye (London, England)"},{"key":"pone.0234186.ref004","doi-asserted-by":"crossref","first-page":"133e1","DOI":"10.1016\/j.ajo.2015.09.039","article-title":"Clinical and Molecular Inflammatory Response in Sjogren Syndrome-Associated Dry Eye Patients Under Desiccating Stress","volume":"161","author":"A Lopez-Miguel","year":"2016","journal-title":"American journal of ophthalmology"},{"key":"pone.0234186.ref005","doi-asserted-by":"crossref","first-page":"129873","DOI":"10.1155\/2008\/129873","article-title":"Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention","volume":"2008","author":"SA Yoo","year":"2008","journal-title":"Mediators of inflammation"},{"issue":"7","key":"pone.0234186.ref006","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"C Cursiefen","year":"2004","journal-title":"The Journal of clinical investigation"},{"issue":"1","key":"pone.0234186.ref007","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archophthalmol.2011.266","article-title":"Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease","volume":"130","author":"S Goyal","year":"2012","journal-title":"Archives of ophthalmology (Chicago, Ill: 1960)"},{"issue":"10","key":"pone.0234186.ref008","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"Y Koenig","year":"2009","journal-title":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"issue":"1","key":"pone.0234186.ref009","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","article-title":"Minimal clinically important difference for the ocular surface disease index","volume":"128","author":"KL Miller","year":"2010","journal-title":"Archives of ophthalmology (Chicago, Ill: 1960)"},{"issue":"7","key":"pone.0234186.ref010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"AJ Bron","year":"2003","journal-title":"Cornea"},{"issue":"1","key":"pone.0234186.ref011","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"W Stevenson","year":"2012","journal-title":"Archives of ophthalmology (Chicago, Ill: 1960)"},{"issue":"3","key":"pone.0234186.ref012","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"AJ Bron","year":"2017","journal-title":"The ocular surface"},{"issue":"11","key":"pone.0234186.ref013","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","article-title":"Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies","volume":"28","author":"T Shih","year":"2006","journal-title":"Clinical therapeutics"},{"key":"pone.0234186.ref014","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"A Enriquez-de-Salamanca","year":"2010","journal-title":"Molecular vision"},{"key":"pone.0234186.ref015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2147\/OPTH.S174290","article-title":"Trehalose\/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients","volume":"12","author":"C Fariselli","year":"2018","journal-title":"Clinical ophthalmology (Auckland, NZ)"},{"issue":"7","key":"pone.0234186.ref016","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.18632\/oncotarget.14615","article-title":"Role of VEGF-A in chronic pain","volume":"8","author":"RP Hulse","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0234186.ref017","article-title":"Central VEGF-A pathway plays a key role in the development of trigeminal neuropathic pain in rats","author":"GW Lee","year":"2019","journal-title":"Molecular pain"},{"issue":"1","key":"pone.0234186.ref018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3892\/ol.2016.5405","article-title":"Correlation between liver cancer pain and the HIF-1 and VEGF expression levels","volume":"13","author":"G Zhang","year":"2017","journal-title":"Oncology letters"},{"issue":"3","key":"pone.0234186.ref019","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"C Belmonte","year":"2017","journal-title":"The ocular surface"},{"key":"pone.0234186.ref020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3389\/fphar.2018.01267","article-title":"Painful Understanding of VEGF","volume":"9","author":"M Llorian-Salvador","year":"2018","journal-title":"Frontiers in pharmacology"},{"key":"pone.0234186.ref021","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2147\/OPTH.S89700","article-title":"Associations between signs and symptoms of dry eye disease: a systematic review","volume":"9","author":"JD Bartlett","year":"2015","journal-title":"Clinical ophthalmology (Auckland, NZ)"},{"issue":"4","key":"pone.0234186.ref022","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.joco.2018.05.002","article-title":"Association between dry eye symptoms and signs","volume":"30","author":"S Kyei","year":"2018","journal-title":"Journal of current ophthalmology"},{"issue":"6","key":"pone.0234186.ref023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/ICL.0000000000000218","article-title":"Dry Eye Disease: Concordance Between the Diagnostic Tests in African Eyes","volume":"42","author":"SN Onwubiko","year":"2016","journal-title":"Eye & contact lens"},{"key":"pone.0234186.ref024","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2147\/OPTH.S33588","article-title":"Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology","volume":"6","author":"C Unlu","year":"2012","journal-title":"Clinical ophthalmology (Auckland, NZ)"},{"issue":"3","key":"pone.0234186.ref025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","article-title":"Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis","volume":"13","author":"KH Wan","year":"2015","journal-title":"The ocular surface"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T01:16:10Z","timestamp":1722993370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0234186"}},"subtitle":[],"editor":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0234186","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]}}}